Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 GeneticVariation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011 2016
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer. 25989278 2015
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1. 24163374 2014
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis. 24594804 2014
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Prospective enterprise-level molecular genotyping of a cohort of cancer patients. 25157968 2014
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth. 23812671 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention. 23845441 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. 23325582 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR BRAF V600E is a determinant of sensitivity to proteasome inhibitors. 24107445 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer. 23549875 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. 23251002 2013
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma. 22535154 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. 22281684 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. 22180495 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR The road to resistance: EGFR mutation and cetuximab. 22310681 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. 22608338 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. 22448344 2012
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis. 20857202 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR BRAF as a target for cancer therapy. 21426297 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. 21163703 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis. 21716161 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. 21343559 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. 21190184 2011
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.500 CausalMutation group CLINVAR Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. 20619739 2010